Nutritional management of cirrhosis patients: A qualitative study exploring perceptions of patients and health workers in Ghana.


Journal

Clinical nutrition ESPEN
ISSN: 2405-4577
Titre abrégé: Clin Nutr ESPEN
Pays: England
ID NLM: 101654592

Informations de publication

Date de publication:
12 2019
Historique:
received: 12 07 2019
revised: 30 08 2019
accepted: 17 09 2019
entrez: 4 11 2019
pubmed: 5 11 2019
medline: 2 9 2020
Statut: ppublish

Résumé

Malnutrition is common among patients with end stage liver disease including liver cirrhosis and liver cancer. Optimal nutrition is important to reduce morbidity and mortality of these patients. There is limited qualitative data on nutritional status and management of chronic liver disease patients. We aimed to explore the knowledge, opinions and practices of cirrhosis patients and health workers in nutritional management of cirrhosis in Ghana, in order to determine whether there is a need to improve nutritional care for cirrhosis patients. We conducted a qualitative study using semi-structured interviews of cirrhotic patients (n = 16) and healthcare providers (n = 27) in three academic centers in Accra, Kumasi and Cape Coast (Ghana). Recruitment was by purposive sampling of patients attending specialist liver disease clinics. The recorded data were analyzed using NVivo 11 software, with generation of codes, themes and subthemes. The major themes that emerged from the data included nutrition as part of care delivery during the hospital visit, nutritional recommendations, dietary changes and long-term practice improvement. The results showed that patients and health workers felt dietary recommendations for patients were frequently addressed, but could be significantly improved. We found that in the opinion of study participants, local guidelines are important and necessary in nutritional management of cirrhosis patients, and that participants felt it was difficult to change dietary habits following cirrhosis diagnosis. These results suggest that nutritional management of cirrhosis patients in Ghana requires improvement. Strategies to improve this could include a multi-disciplinary approach to nutritional management, development of local guidelines and continued nutritional assessment, monitoring and follow-up.

Sections du résumé

BACKGROUND AND AIMS
Malnutrition is common among patients with end stage liver disease including liver cirrhosis and liver cancer. Optimal nutrition is important to reduce morbidity and mortality of these patients. There is limited qualitative data on nutritional status and management of chronic liver disease patients. We aimed to explore the knowledge, opinions and practices of cirrhosis patients and health workers in nutritional management of cirrhosis in Ghana, in order to determine whether there is a need to improve nutritional care for cirrhosis patients.
METHODS
We conducted a qualitative study using semi-structured interviews of cirrhotic patients (n = 16) and healthcare providers (n = 27) in three academic centers in Accra, Kumasi and Cape Coast (Ghana). Recruitment was by purposive sampling of patients attending specialist liver disease clinics. The recorded data were analyzed using NVivo 11 software, with generation of codes, themes and subthemes.
RESULTS
The major themes that emerged from the data included nutrition as part of care delivery during the hospital visit, nutritional recommendations, dietary changes and long-term practice improvement. The results showed that patients and health workers felt dietary recommendations for patients were frequently addressed, but could be significantly improved. We found that in the opinion of study participants, local guidelines are important and necessary in nutritional management of cirrhosis patients, and that participants felt it was difficult to change dietary habits following cirrhosis diagnosis.
CONCLUSIONS
These results suggest that nutritional management of cirrhosis patients in Ghana requires improvement. Strategies to improve this could include a multi-disciplinary approach to nutritional management, development of local guidelines and continued nutritional assessment, monitoring and follow-up.

Identifiants

pubmed: 31677706
pii: S2405-4577(19)30466-8
doi: 10.1016/j.clnesp.2019.09.010
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18-22

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Yvonne Ayerki Nartey (YA)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Internal Medicine, School of Medical Sciences University of Cape Coast, Cape Coast, Ghana. Electronic address: yvonne.nartey@ki.se.

Mawuena Asem (M)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Adwoa Agyei-Nkansah (A)

Department of Medicine, Korle Bu Teaching Hospital, Accra, Ghana.

Yaw Asante Awuku (YA)

Department of Internal Medicine, School of Medical Sciences University of Cape Coast, Cape Coast, Ghana.

Jacob Setorglo (J)

Department of Clinical Nutrition and Dietetics, School of Medical Sciences University of Cape Coast, Cape Coast, Ghana.

Amoako Duah (A)

Department of Medicine, Korle Bu Teaching Hospital, Accra, Ghana.

Sally Bampoh (S)

Department of Medicine, Korle Bu Teaching Hospital, Accra, Ghana.

Joshua Ayawin (J)

Department of Medicine, Komfo-Anokye Teaching Hospital, Kumasi, Ghana.

Shadrack Osei Asibey (SO)

Catholic University College, Ghana.

Weimin Ye (W)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Mary Yeboah Afihene (MY)

Department of Medicine, Komfo-Anokye Teaching Hospital, Kumasi, Ghana.

Lewis Roberts (L)

Division of Gastroenterology and Hepatology, Mayo Clinic Rochester, Minnesota, USA.

Amelie Plymoth (A)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH